CAM
AMED

Claret Asset Management’s Amedisys AMED Stock Holding History

Claret Asset Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,377
Closed -$234K – 411
2025
Q2 		$234K Buy
+2,377
New +$225K 0.03% 261

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Claret Asset Management's AMED Position: Q3 2025 in Review

Claret Asset Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 2,377 shares — an estimated $234K sold.

Claret Asset Management first reported a position in AMED in Q2 2025 and held it in 1 quarter. The position peaked at $234K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Claret Asset Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Claret Asset Management sold 2,377 Amedisys shares in Q3 2025, an estimated $234K.
  • Claret Asset Management first reported a position in Amedisys in Q2 2025 and held it in 1 quarter.
  • Claret Asset Management's Amedisys position peaked at $234K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Claret Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.